# Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma

> **NCT00195871** · PHASE2 · UNKNOWN · sponsor: **Centre Henri Becquerel** · enrollment: 155 (actual)

## Conditions studied

- Lymphoblastic Lymphoma

## Interventions

- **DRUG:** Prednisone, vincristine, daunorubicin , cyclophosphamide , L.-asparaginase, cytosine-arabinoside, methotrexate, etoposide
- **PROCEDURE:** hematopoietic stem cell allograft

## Key facts

- **NCT ID:** NCT00195871
- **Lead sponsor:** Centre Henri Becquerel
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-02
- **Primary completion:** 2014-06
- **Final completion:** 2015-12
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2013-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195871, "Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00195871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*